Recruiting Halt Aging in Survivors of Blood Cancers NCT07292272 Conditions Blood Protein Disorders, Cardiovascular Diseases, Hematologic Diseases, +29 more Locations University of Nebraska Medical Center — Omaha, Nebraska, United States View Trial Details
Recruiting Mitoxantrone for Venetoclax Resistant Acute Myeloid Leukemia NCT06429449 Conditions Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +7 more Locations University of Colorado Hospital — Aurora, Colorado, United States View Trial Details
Completed Enasidenib in MDS &Non-proliferative Chronic Myelomonocytic Leukemia w/o IDH2 Mutation NCT05282459 Conditions Hematologic Diseases, Hemic and Lymphatic Diseases, Leukemia, +6 more Locations Stanford Cancer Institute — Palo Alto, California, United States View Trial Details
Completed FT538 in Combination With Daratumumab in AML Acute Myeloid Leukemia NCT04714372 Conditions Acute Myeloid Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +8 more Locations Masonic Cancer Center, University of Minnesota — Minneapolis, Minnesota, United States View Trial Details
Completed Therapeutic Use of Intravenous Vitamin C in Allogeneic Stem Cell Transplant Recipients NCT03613727 Conditions Anemia, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, +20 more Locations Virginia Commonwealth University/ Massey Cancer Center — Richmond, Virginia, United States View Trial Details
Active, Not Recruiting Integrated Actionable Aging Assessment for Cancer Patients Pilot NCT05871008 Conditions Bladder Cancer, Blood Protein Disorders, Breast Cancer, +49 more Locations University of Colorado Hospital — Aurora, Colorado, United States View Trial Details
